Alaunos Therapeutics TCRT
NASDAQ TCRT
$0.82 -0.08 (-8.89%)
At close: Oct 2, 2026 · 4:00 PM EDT

Alaunos Therapeutics (TCRT) Selling, General & Administrative (2009 - 2026)

Updated

Alaunos Therapeutics (TCRT) posted Selling, General & Administrative of $564,000 for Q2 2026, down 34.0% from $854,000 a year earlier and down 3.6% from the prior quarter.

Analysis

Alaunos Therapeutics (TCRT) Selling, General & Administrative (2009 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Selling, General & Administrative at Alaunos Therapeutics was $2.42 million, down 30.0% year-over-year; for FY2025, it came in at $2.87 million, down 35.7% from FY2024.

  • Annual Selling, General & Administrative has declined for five consecutive years, with a five-year compound annual growth rate of -36.5% (FY2020 to FY2025).
  • In prior years, Alaunos Therapeutics' Selling, General & Administrative was $4.46 million in FY2024 (-63.5%), $12.22 million in FY2023 (-7.0%), $13.14 million in FY2022 (-52.3%) and $27.56 million in FY2021 (-0.4%).
  • Quarterly Selling, General & Administrative has run from a low of $549,000 in Q4 2025 to a high of $8.17 million in Q3 2021 over five years.
  • On a year-over-year basis, Selling, General & Administrative has declined in each of the last 11 quarters, with an average decline of 40.5% over the last eight quarters.
  • The strongest year-over-year quarter for Selling, General & Administrative in the past five years was Q4 2022, with growth of 39.6%; the weakest was Q4 2021, with a decline of 76.2%.
  • According to Business Quant data, Selling, General & Administrative for the three prior quarters was $585,000 (Q1 2026), $549,000 (Q4 2025) and $718,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 6.43 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.63 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -5.65 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.92 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 3.41 Bn
10 Alaunos Therapeutics 2.04 Mn -1.76 Mn - 564,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 564,000.00
Mar 31, 2026 585,000.00
Dec 31, 2025 549,000.00
Sep 30, 2025 718,000.00
Jun 30, 2025 854,000.00
Mar 31, 2025 747,000.00
Dec 31, 2024 845,000.00
Sep 30, 2024 1.01 Mn
Jun 30, 2024 990,000.00
Mar 31, 2024 1.62 Mn
Dec 31, 2023 2.43 Mn
Sep 30, 2023 3.58 Mn
Jun 30, 2023 3.05 Mn
Mar 31, 2023 3.17 Mn
Dec 31, 2022 2.93 Mn
Sep 30, 2022 3.28 Mn
Jun 30, 2022 3.43 Mn
Mar 31, 2022 3.51 Mn
Dec 31, 2021 2.10 Mn
Sep 30, 2021 8.17 Mn
API Access

Alaunos Therapeutics Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=TCRT&period=max&api_key=YOUR_API_KEY